Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.33 |
| ▸ | CPA1 | P15085 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29105547 | 0.81 | HCAR2 (0.38) | ALDH1A1LMNAHCAR2 | |
| SCHEMBL18239536 | 0.80 | TSHR (0.53) | ALDH1A1NPSR1TSHRHCAR2L3MBTL1 | |
| SCHEMBL8469191 | 0.80 | TSHR (0.53) | ALDH1A1NPSR1TSHRHCAR2L3MBTL1 | |
| SCHEMBL8469724 | 0.80 | — | — | |
| SCHEMBL793641 | 0.80 | ALDH1A1 (0.40) | ALDH1A1NPSR1LMNAHSD17B10TSHR | |
| SCHEMBL770455 | 0.80 | TSHR (0.41) | ALDH1A1NPSR1HSD17B10TSHRCPA1 | |
| SCHEMBL3068583 | 0.80 | — | — | |
| SCHEMBL891773 | 0.80 | CPA1 (0.42) | ALDH1A1NPSR1LMNAHSD17B10TSHR | |
| SCHEMBL29059967 | 0.79 | ALDH1A1 (0.38) | ALDH1A1NPSR1LMNAHSD17B10TSHR | |
| SCHEMBL21463245 | 0.79 | TSHR (0.53) | ALDH1A1LMNAHSD17B10TSHRGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313574-A1 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2025-10-09 | — | — | US | disclosed |
| US-20250243427-A1 | PRECURSORS OF PHENOLIC FRAGRANT COMPOUNDS | GIVAUDAN SA (CH) | 2025-07-31 | — | — | US | disclosed |
| US-20250186408-A1 | TREATMENT OF PHARMACORESISTANT EPILEPSY | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2025-06-12 | — | — | US | disclosed |
| WO-2025104443-A1 | INHIBITORY COMPOUNDS | STORM THERAPEUTICS LTD (GB) | 2025-05-22 | — | — | WO | disclosed |
| EP-4536653-A2 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | Eisai R&D Management Co., Ltd. (JP) | 2025-04-16 | — | — | EP | disclosed |
| EP-4419497-A1 | PRECURSORS OF PHENOLIC FRAGRANT COMPOUNDS | Givaudan SA (CH) | 2024-08-28 | — | — | EP | disclosed |
| CN-118119588-A | Precursors for phenolic aromatic compounds | 奇华顿股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| EP-4333819-A1 | TREATMENT OF PHARMACORESISTANT EPILEPSY | Katholieke Universiteit Leuven (BE) | 2024-03-13 | — | — | EP | disclosed |
| WO-2023239906-A2 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2023-12-14 | — | — | WO | disclosed |
| CN-116813823-A | Supported catalyst, preparation method thereof and application thereof in photocatalytic polymerization | 北京服装学院 | 2023-09-29 | — | — | CN | disclosed |
| US-7402608-B2 | Compounds and methods for the treatment or prevention of Flavivirus infections | VIROCHEM PHARMA INC. (CA) | 2008-07-22 | — | — | US | disclosed |
| US-7314943-B2 | Pyran derivatives containing an exocyclic double bond | MERCK PATENT GMBH (DE) | 2008-01-01 | — | — | US | disclosed |
| US-7314943-B2 | Pyran derivatives containing an exocyclic double bond | MERCK PATENT GMBH (DE) | 2008-01-01 | — | — | US | disclosed |
| US-7314943-B2 | Pyran derivatives containing an exocyclic double bond | MERCK PATENT GMBH (DE) | 2008-01-01 | — | — | US | disclosed |
| EP-1482020-B1 | Pyran derivatives with an exocyclic double bond | MERCK PATENT GMBH (DE) | 2006-09-06 | — | — | EP | disclosed |
| EP-1569929-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF i FLAVIVIRUS /i INFECTIONS | Virochem Pharma Inc. (CA) | 2005-09-07 | — | — | EP | disclosed |
| US-20050038267-A1 | Pyran derivatives containing an exocyclic double bond | MERCK PATENT GMBH (DE) | 2005-02-17 | — | — | US | disclosed |
| US-20050009804-A1 | Compounds and methods for the treatment or prevention of Flavivirus infections | VERTEX PHARMACEUTICALS (CANADA) INCORPORATED (CA) | 2005-01-13 | — | — | US | disclosed |
| EP-1482020-A1 | Pyran derivatives with an exocyclic double bond | MERCK PATENT GmbH (DE) | 2004-12-01 | — | — | EP | disclosed |
| WO-2004052885-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | VIROCHEM PHARMA INC. (CA) | 2004-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009804-A1 | Compounds and methods for the treatment or prevention of Flavivirus infections | ZC3HAV1, ZYX, ZFX | ALDH1A1 1591/4885NPSR1 3295/4885LMNA 1242/4885 |
| US-20050038267-A1 | Pyran derivatives containing an exocyclic double bond | EXOC1, EDF1, EIF4A1 | ALDH1A1 1096/4885NPSR1 2586/4885LMNA 618/4885 |
| US-20250186408-A1 | TREATMENT OF PHARMACORESISTANT EPILEPSY | CNR1, CNR2, CYP2J2 | ALDH1A1 1412/4885NPSR1 233/4885LMNA 2454/4885 |
| US-20250243427-A1 | PRECURSORS OF PHENOLIC FRAGRANT COMPOUNDS | FOS, HAAO, HPD | ALDH1A1 843/4885NPSR1 1231/4885LMNA 1960/4885 |
| US-20250313574-A1 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | NEU1, NEU2, NEU4 | ALDH1A1 474/4885NPSR1 508/4885LMNA 1117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.